Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in a Case of Concurrent Neuroendocrine Tumors and Meningioma: Achieving Two Things in a Single Action

被引：4
|
作者：
Assadi, Majid [1 ]
Rekabpour, Seyed Javad [2 ]
Amini, Abdullatif [3 ]
Dadgar, Habibollah [4 ]
Nemati, Reza [5 ]
Gholamrezanezhad, Ali [6 ]
Nabipour, Iraj [7 ]
Jafari, Esmail [1 ]
Ahmadzadehfar, Hojjat [8 ]
机构：
[1] Bushehr Univ Med Sci, Bushehr Med Univ Hosp, Persian Gulf Nucl Med Res Ctr, Dept Mol Imaging & Radionuclide Therapy, Bushehr, Iran
[2] Bushehr Univ Med Sci, Bushehr Med Univ Hosp, Dept Oncol, Bushehr, Iran
[3] Bushehr Univ Med Sci, Bushehr Med Heart Ctr, Dept Cardiol, Bushehr, Iran
[4] Imam Reza Int Univ, RAZAVI Hosp, Canc Res Ctr, Mashhad, Razavi Khorasan, Iran
[5] Bushehr Univ Med Sci, Bushehr Med Univ Hosp, Dept Neurol, Bushehr, Iran
[6] Univ Southern Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA 90007 USA
[7] Bushehr Univ Med Sci, Bushehr Med Univ Hosp, Dept Internal Med, Div Endocrinol, Bushehr, Iran
[8] Klinikum Westfalen, Dept Nucl Med, Dortmund, Germany
来源：
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY | 2021年 / 30卷 / 02期
关键词：
Ga-68-DOTATATE PET/MRI; PRRT; neuroendocrine tumor; F-18-FDG-PET/CT;
D O I：
10.4274/mirt.galenos.2020.69783
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：107 / 109
页数：3
相关论文
共 50 条
  • [1] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [2] 177Lu-Dotatate Peptide Receptor Radionuclide Therapy Dose Response in Small Intestinal Neuroendocrine Tumors
    Jahn, U. M. M.
    Ilan, E.
    Sandstrom, M.
    Bamerny, M.
    Garske-Roman, U.
    Lubberink, M.
    Sundin, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S157 - S158
  • [3] 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy: Dose Response in Small Intestinal Neuroendocrine Tumors
    Jahn, Ulrika
    Ilan, Ezgi
    Sandstrom, Mattias
    Garske-Roman, Ulrike
    Lubberink, Mark
    Sundin, Anders
    [J]. NEUROENDOCRINOLOGY, 2020, 110 (7-8) : 662 - 670
  • [4] Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors
    Abou Jokh Casas, E.
    Pombo Pasin, M. D.
    Pubul Nunez, V.
    Garrido Pumar, M.
    Blanco Freire, M. N.
    Cabezas, J.
    Cameselle, J.
    Berrios, M.
    Argibay, S.
    Ruibal Morell, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S597 - S598
  • [5] Management of a Patient With Metastatic Gastrointestinal Neuroendocrine Tumor and Meningioma Submitted to Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE
    Pirisino, Riccardo
    Filippi, Luca
    D'Agostini, Antonio
    Bagni, Oreste
    [J]. CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : E692 - E695
  • [6] A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors
    Kasi, Pashtoon Murtaza
    Maige, Catherine L.
    Shahjehan, Faisal
    Rodgers, Jessica M.
    Aloszka, Debora L.
    Ritter, Ashton
    Andrus, Margaret L.
    Mcmillan, Jessica M.
    Mody, Kabir
    Sharma, Akash
    Jain, Manoj K.
    [J]. FRONTIERS IN ONCOLOGY, 2019, 8
  • [7] 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy; Gender Differences in Small Intestinal and Pancreatic Neuroendocrine Tumors
    Jahn, U. M. M.
    Jahn, U. M.
    Ilan, E.
    Sandstrom, M.
    Garske-Roman, U.
    Velikyan, I.
    Fross-Baron, K.
    Lubberink, M.
    Sundin, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S61 - S62
  • [8] Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE
    Ilan, Ezgi
    Sandstrom, Mattias
    Wassberg, Cecilia
    Sundin, Anders
    Garske-Roman, Ulrike
    Eriksson, Barbro
    Granberg, Dan
    Lubberink, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) : 177 - 182
  • [9] Renal and Hematological Toxicity in Patients of Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
    Gupta, Santosh K.
    Singla, Suhas
    Bal, Chandrasekhar
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2012, 27 (09) : 593 - 599
  • [10] A Clinical Guide to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients
    Becx, Morticia N.
    Minczeles, Noemie S.
    Brabander, Tessa
    de Herder, Wouter W.
    Nonnekens, Julie
    Hofland, Johannes
    [J]. CANCERS, 2022, 14 (23)
12345